Search - tctmd.com

Displaying 301 - 320 of 327

Sort: Relevancy | Date

News Conference News TCT 2012

Debate Continues with the AUC

October 26, 2012

News Conference News TCT 2012

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

October 25, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Conference News TCT 2012

Flexibility with Future Reform, Contract Negotiations Key to Career Success

October 24, 2012

News Conference News TCT 2012

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

October 24, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Quality of Life: Should This Be the Key Parameter in Choosing Therapies?

Presenter: John Spertus

October 22, 2012

Presentation TCT 2012

Quality Control: Investigator's Responsibilities

Presenter: Alexandra Lansky

October 22, 2012

News Conference News TCT 2012

PCI Associated with Lower Stroke Risk Than CABG

October 22, 2012

News Conference News TCT 2012

PARTNER Analyses Provide Important Insights into TAVR

October 22, 2012

Presentation TCT 2012

OK, PCI May Be Performed at Low Volume Centers with No On-site Surgery, But Are There Quality and Cost Advantages to Centralizing Care?

Presenter: James Hermiller Jr

October 22, 2012

Presentation TCT 2012

Lessons from the Quality-of-Life Studies in Inoperable and High-Risk Patients

Presenter: David Cohen

October 22, 2012

News Conference News TCT 2012

Globalization of Innovation a ‘Must Have’ to Improve Health Care Delivery

October 22, 2012

Presentation TCT 2012

Reduced Coronary Angioplasty Screening Frame Rate Significantly Lowers Radiation Exposure Without Affecting Image Quality or Patient Outcome

Presenter: Sam J. Wilson

January 03, 2012

Presentation TCT 2012

Quality Of Life Changes In High Risk Patients after Percutaneous Mitral Valve Repair with Mitraclip

Presenter: Maurizio Taramasso, Paolo Denti, Micaela Cioni, Nicola Buzzatti, Antonio Colombo, Ottavio Alfieri, Francesco Maisano

January 03, 2012

Presentation TCT 2012

Fast track Carotid Surgery is the gold standard for High-risk (HRP) Carotid Artery Intervention: Five year Cost-effectiveness and Quality Stroke Free Survival comparison

Presenter: Sherif Sultan, Niamh Hynes

January 03, 2012

News Conference News

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

November 09, 2011

News Conference News

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

November 09, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

DEB Promising in Critical Limb Ischemia, Femoropopliteal Arterial Disease

November 08, 2011

Advertisement

Debate Continues with the AUC

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

Flexibility with Future Reform, Contract Negotiations Key to Career Success

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

Quality-of-Life and Cost-Effectiveness After LAA Closure

Quality of Life: Should This Be the Key Parameter in Choosing Therapies?

Quality Control: Investigator's Responsibilities

PCI Associated with Lower Stroke Risk Than CABG

PARTNER Analyses Provide Important Insights into TAVR

OK, PCI May Be Performed at Low Volume Centers with No On-site Surgery, But Are There Quality and Cost Advantages to Centralizing Care?

Lessons from the Quality-of-Life Studies in Inoperable and High-Risk Patients

Globalization of Innovation a ‘Must Have’ to Improve Health Care Delivery

Reduced Coronary Angioplasty Screening Frame Rate Significantly Lowers Radiation Exposure Without Affecting Image Quality or Patient Outcome

Quality Of Life Changes In High Risk Patients after Percutaneous Mitral Valve Repair with Mitraclip

Fast track Carotid Surgery is the gold standard for High-risk (HRP) Carotid Artery Intervention: Five year Cost-effectiveness and Quality Stroke Free Survival comparison

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. Surgery

Low Event Rates with EES Sustained at 2 Years

DEB Promising in Critical Limb Ischemia, Femoropopliteal Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content